Literature DB >> 11291533

Gynecomastia induced by treatment with tandospirone, a 5-HT1A agonist.

Y Kaneda, T Morimoto, A Fujii.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11291533      PMCID: PMC1407752     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  6 in total

1.  Adverse reactions of selective serotonin reuptake inhibitors: reports from a spontaneous reporting system.

Authors:  O Spigset
Journal:  Drug Saf       Date:  1999-03       Impact factor: 5.606

2.  Breast pain associated with venlafaxine.

Authors:  S C Bhatia; S Gupta; K A Theesen
Journal:  J Clin Psychiatry       Date:  1996-09       Impact factor: 4.384

3.  Pharmacological properties of SM-3997: a new anxioselective anxiolytic candidate.

Authors:  H Shimizu; A Hirose; T Tatsuno; M Nakamura; J Katsube
Journal:  Jpn J Pharmacol       Date:  1987-12

Review 4.  Gynecomastia.

Authors:  H E Carlson
Journal:  N Engl J Med       Date:  1980-10-02       Impact factor: 91.245

Review 5.  Drug-induced gynecomastia.

Authors:  D F Thompson; J R Carter
Journal:  Pharmacotherapy       Date:  1993 Jan-Feb       Impact factor: 4.705

6.  Hyperprolactinaemia and impotence.

Authors:  S Franks; H S Jacobs; N Martin; J D Nabarro
Journal:  Clin Endocrinol (Oxf)       Date:  1978-04       Impact factor: 3.478

  6 in total
  2 in total

Review 1.  Gynecomastia and drugs: a critical evaluation of the literature.

Authors:  Frank Q Nuttall; Rohit S Warrier; Mary C Gannon
Journal:  Eur J Clin Pharmacol       Date:  2015-04-02       Impact factor: 2.953

2.  Bipolar disorder, comorbid anxiety disorders, gynecomastia and dental pain: case analysis with literature review.

Authors:  Kenneth R Kaufman; Ronke Babalola; Miriam Campeas; Melissa Coluccio
Journal:  BJPsych Open       Date:  2018-04-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.